Hanne-Dorthe Emborg

Hanne-Dorthe Emborg

Contact

Hanne-Dorthe Emborg
T. +45 32683937 @. hde@ssi.dk

Research area

The main research area is register based influenza vaccine effectiveness at national and international level through the EU funded projects I-MOVE and I-MOVE+. Involved in various aspect of vaccine preventable disease research and in particular in studies on methods to estimate vaccine coverage through the European project ADVANCE. Has also been involved in salmonella and campylobacter sero-epidemiology in Europe and antimicrobial resistance research.

Pubmed link

https://www.ncbi.nlm.nih.gov/pubmed/?term=emborg+hd

Responsibilities

National mid-season and end-of-season influenza vaccine effectiveness estimation

The European projects I-MOVE+, ADVANCE and JAV

The project “Associations between acute respiratory infections and cardio-vascular events” funded by the Danish Heart Foundation

Publications

Rondy M, Kissling E, Emborg HD, Gherasim A, Pebody R, Trebbien R, Pozo F, Larrauri A, McMenamin J, Valenciano M; I-MOVE/I-MOVE+ group. 2018. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. Euro Surveill. 2018 Mar;23(9). doi: 10.2807/1560-7917.ES.2018.23.9.18-00086

Trebbien R, Fischer TK, Krause TG, Nielsen L, Nielsen XC, Weinreich LS, Lis-Tønder J, Skov MN, Christiansen CB, Emborg HD. 2017. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark. J Clin Virol. Sep;94:1-7. doi: 10.1016/j.jcv.2017.06.007. Epub 2017 Jun 29

Emborg HD, Krause TG, Nielsen L, Thomsen MK, Christiansen CB, Skov MN, Nielsen XC, Weinreich LS, Fischer TK, Rønn J, Trebbien R. 2016. Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid

Emborg HD, Teunis P, Simonsen J, Krogfelt KA, Jørgensen CS, Takkinen J, Mølbak K. 2015. Was the increase in culture-confirmed Campylobacter infections in Denmark during the 1990s a surveillance artefact? Euro Surveill.Oct 15;20(41). doi: 10.2807/1560-7917.ES.2015.20.41.30041.epidemiological and virological assessment. Euro Surveill. 21(14). doi: 10.2807/1560-7917.ES.2016.21.14.30189.

Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K. 2012. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10. BMJ. Jan 25;344:d7901. doi: 10.1136/bmj.d7901.